Equities

Bliss GVS Pharma Ltd

BLISSGVS:NSI

Bliss GVS Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)135.94
  • Today's Change5.79 / 4.45%
  • Shares traded3.78m
  • 1 Year change+47.20%
  • Beta0.6879
Data delayed at least 15 minutes, as of Sep 23 2024 11:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Monday, Bliss GVS Pharma Ltd (BLISSGVS:NSI) closed at 135.94, -9.13% below its 52-week high of 149.60, set on Nov 28, 2023.
52-week range
Today
77.35Oct 26 2023149.60Nov 28 2023
Open131.00
High140.80
Low131.00
Bid135.94
Offer135.94
Previous close130.15
Average volume1.50m
Shares outstanding105.03m
Free float39.41m
P/E (TTM)17.02
Market cap13.64bn INR
EPS (TTM)7.63
INR
Annual div (ADY)0.50
INR
Annual div yield (ADY)0.38%
Div ex-dateJul 18 2024
Div pay-dateAug 24 2024
Data delayed at least 15 minutes, as of Sep 23 2024 11:29 BST.
More ▼

Events & Activity

  • BLISSGVS:NSI trading volume exceeds daily average by +143.50%
  • BLISSGVS:NSI price moved over +1.62% to 129.95
  • BLISSGVS:NSI price rises above 15-day moving average to 128.41 at 03:00 BST
  • BLISSGVS:NSI price rises above 15-day moving average to 129.95 at 00:37 BST
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.